Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • BFSI
      • Capital Goods
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Business»Dr. Ajit Kamath, Managing Director Of Arch Pharmalabs Ltd Conferred Honorary Doctorate in Health Administration by Indian Institute of Technical Research and Business Studies
    Business

    Dr. Ajit Kamath, Managing Director Of Arch Pharmalabs Ltd Conferred Honorary Doctorate in Health Administration by Indian Institute of Technical Research and Business Studies

    By February 2, 2022No Comments2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    New Delhi (India), February 02: Dr. Ajit Kamath, Promoter and Managing Director of Arch Pharmalabs Ltd, was conferred “Honorary Doctorate in Health Administration by prestigious University The Indian Institute of Technical Research and Business Studies For his exemplary contribution of over 25 years in the field of Pharmaceuticals in a virtual ceremony commemorating  73 Years of the Republic of India.

    Arch Pharmalabs Ltd. is a Mumbai Headquartered company based in India. Arch has multiple USFDA approved facilities with multiple chemistry capabilities from kilogram to multi-ton scale. Arch has been at the forefront of attracting and practising path-breaking technologies in the field of manufacturing of Active Pharmaceutical Ingredients and Intermediates. Arch has been manufacturing, commercially, various import substitutes and complex intermediates covering, but not limited to, blockbuster drugs like Atorvastatin, Rosuvastatin, Ursodeoxycholic Acid etc.

    Recently it has also diversified into Lithium compounds.

    For over two and a half decades, Dr. Ajit Kamath has had extensive top-level decision-making and risk-taking experience in Arch Pharmalabs Limited’s dynamic global business. Accepting the degree, Dr.  Ajit Kamath said, “I am extremely honoured to receive this Honorary Doctorate from a University that plays such an important role in developing the potential and talent of tens of thousands of students from all over the world. May you all be fortunate enough to know someone who will inspire you to feel the joy and satisfaction that comes from helping others.”

    For more information, please visit http://www.archpharmalabs.com/

    Business
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Bamboo summit in Mumbai to bring state’s bamboo policy before investors

    September 18, 2026

    Global Experts Deliberate on Democracy in the Age of AI at DSVV

    September 17, 2026

    Prime Car Care Is Changing How People Discover PPF — Before the Damage, Not After

    September 17, 2026

    Comments are closed.

    Recent Post
    • Bamboo summit in Mumbai to bring state’s bamboo policy before investors
    • Global Experts Deliberate on Democracy in the Age of AI at DSVV
    • Prime Car Care Is Changing How People Discover PPF — Before the Damage, Not After
    • Dyslexia Symptoms in Children Often Mistaken for Laziness, Says Indore based Child Psychologist Dr Vini — Here’s What Parents Should Know Before Exam Season
    • Signoff Launches Enterprise Agentic AI Intelligence Platform
    • Captain Polyplast Secures Rs 47 Cr Order from MSEDCL for 2,000 Solar Pumps
    • Allwyn Bikes Enters a New Chapter with Exclusive Bicycle Launch, Bringing German Design to Indian Manufacturing
    • Captain Polyplast Limited Strengthens Solar EPC Order Book with Rs 47 Cr Order for 2,000 Solar Pumps from MSEDCL

    Type above and press Enter to search. Press Esc to cancel.